🇺🇸 Mometasone Nasal Spray in United States

22 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Confusional State — 4 reports (18.18%)
  2. Hyperaesthesia — 3 reports (13.64%)
  3. Adrenal Insufficiency — 2 reports (9.09%)
  4. Depression — 2 reports (9.09%)
  5. Dysphonia — 2 reports (9.09%)
  6. Incorrect Dose Administered — 2 reports (9.09%)
  7. Mental Disorder — 2 reports (9.09%)
  8. Product Barcode Issue — 2 reports (9.09%)
  9. Somnolence — 2 reports (9.09%)
  10. Accidental Exposure To Product — 1 report (4.55%)

Source database →

Mometasone Nasal Spray in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Mometasone Nasal Spray approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Mometasone Nasal Spray in United States?

Washington University School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.